论文部分内容阅读
Placebo-controlled phase Ⅲ study comparing dexamethasone on day 1 to on day 1-3 with NK1 receptor an
【作 者】
：
【机 构】
：
Department of Pharmacy,St.Marianna University Breast & Imaging Center,Kawasaki,Japan
【出 处】
：
2016年临床肿瘤学新进展学术研讨会
【发表日期】
：
2016年5期
其他文献
Updated results from a phase Ⅲ trial of nivolumab(NIVO)combined with ipilimumab(IPI)in treatment-nai
会议
会议
Lenalidomide(LEN)maintenance(MNTC)after high-dose melphalan and autologous stem cell transplant(ASCT
会议
Phase Ⅲ randomized controlled study of daratumumab,bortezomib,and dexamethasone(DVd)versus bortezomi
会议
Pembrolizumab versus ipilimumab for advanced melanoma:Final overall survival analysis of KEYNOTE-006
会议
Genomic analysis and 3-y efficacy and safety update of COMBI-d:A phase 3 study of dabrafenib(D)+tram
会议
A phase Ⅰb dose escalation trial of isatuximab(SAR650984,anti-CD38 mAb)plus lenalidomide and dexamet
会议
Comorbidities and risk of chemotherapy-induced peripheral neuropathy among participantsin SWOG clini
会议